Akcea Therapeutics, Inc. EBITDA Margin 2017-2020 | AKCA
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Akcea Therapeutics, Inc. (AKCA) over the last 10 years. The current EBITDA margin for Akcea Therapeutics, Inc. as of June 30, 2020 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2020-06-30 | $0.34B | $-0.04B | -11.31% |
| 2020-03-31 | $0.34B | $-0.03B | -7.62% |
| 2019-12-31 | $0.49B | $0.05B | 9.20% |
| 2019-09-30 | $0.22B | $-0.11B | -49.55% |
| 2019-06-30 | $0.22B | $-0.14B | -65.00% |
| 2019-03-31 | $0.21B | $-0.17B | -80.09% |
| 2018-12-31 | $0.06B | $-0.23B | -354.69% |
| 2018-09-30 | $0.08B | $-0.18B | -234.21% |
| 2018-06-30 | $0.07B | $-0.13B | -194.03% |
| 2018-03-31 | $0.06B | $-0.09B | -158.18% |
| 2017-12-31 | $0.04B | $-0.12B | -272.73% |
